Cargando…

Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging

BACKGROUND: Based on conventional MRI images, it is difficult to differentiatepseudoprogression from true progressionin GBM patients after standard treatment, which isa critical issue associated with survival. The aim of this study was to evaluate the diagnostic performance of machine learning using...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ying-Zhi, Yan, Lin-Feng, Han, Yu, Nan, Hai-Yan, Xiao, Gang, Tian, Qiang, Pu, Wen-Hui, Li, Ze-Yang, Wei, Xiao-Cheng, Wang, Wen, Cui, Guang-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860032/
https://www.ncbi.nlm.nih.gov/pubmed/33535988
http://dx.doi.org/10.1186/s12880-020-00545-5
_version_ 1783646858262872064
author Sun, Ying-Zhi
Yan, Lin-Feng
Han, Yu
Nan, Hai-Yan
Xiao, Gang
Tian, Qiang
Pu, Wen-Hui
Li, Ze-Yang
Wei, Xiao-Cheng
Wang, Wen
Cui, Guang-Bin
author_facet Sun, Ying-Zhi
Yan, Lin-Feng
Han, Yu
Nan, Hai-Yan
Xiao, Gang
Tian, Qiang
Pu, Wen-Hui
Li, Ze-Yang
Wei, Xiao-Cheng
Wang, Wen
Cui, Guang-Bin
author_sort Sun, Ying-Zhi
collection PubMed
description BACKGROUND: Based on conventional MRI images, it is difficult to differentiatepseudoprogression from true progressionin GBM patients after standard treatment, which isa critical issue associated with survival. The aim of this study was to evaluate the diagnostic performance of machine learning using radiomics modelfrom T(1)-weighted contrast enhanced imaging(T(1)CE) in differentiating pseudoprogression from true progression after standard treatment for GBM. METHODS: Seventy-sevenGBM patients, including 51 with true progression and 26 with pseudoprogression,who underwent standard treatment and T(1)CE, were retrospectively enrolled.Clinical information, including sex, age, KPS score, resection extent, neurological deficit and mean radiation dose, were also recorded collected for each patient. The whole tumor enhancementwas manually drawn on the T(1)CE image, and a total of texture 9675 features were extracted and fed to a two-step feature selection scheme. A random forest (RF) classifier was trained to separate the patients by their outcomes.The diagnostic efficacies of the radiomics modeland radiologist assessment were further compared by using theaccuracy (ACC), sensitivity and specificity. RESULTS: No clinical features showed statistically significant differences between true progression and pseudoprogression.The radiomic classifier demonstrated ACC, sensitivity, and specificity of 72.78%(95% confidence interval [CI]: 0.45,0.91), 78.36%(95%CI: 0.56,1.00) and 61.33%(95%CI: 0.20,0.82).The accuracy, sensitivity and specificity of three radiologists’ assessment were66.23%(95% CI: 0.55,0.76), 61.50%(95% CI: 0.43,0.78) and 68.62%(95% CI: 0.55,0.80); 55.84%(95% CI: 0.45,0.66),69.25%(95% CI: 0.50,0.84) and 49.13%(95% CI: 0.36,0.62); 55.84%(95% CI: 0.45,0.66), 69.23%(95% CI: 0.50,0.84) and 47.06%(95% CI: 0.34,0.61), respectively. CONCLUSION: T(1)CE–based radiomics showed better classification performance compared with radiologists’ assessment.The radiomics modelwas promising in differentiating pseudoprogression from true progression.
format Online
Article
Text
id pubmed-7860032
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78600322021-02-04 Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging Sun, Ying-Zhi Yan, Lin-Feng Han, Yu Nan, Hai-Yan Xiao, Gang Tian, Qiang Pu, Wen-Hui Li, Ze-Yang Wei, Xiao-Cheng Wang, Wen Cui, Guang-Bin BMC Med Imaging Research Article BACKGROUND: Based on conventional MRI images, it is difficult to differentiatepseudoprogression from true progressionin GBM patients after standard treatment, which isa critical issue associated with survival. The aim of this study was to evaluate the diagnostic performance of machine learning using radiomics modelfrom T(1)-weighted contrast enhanced imaging(T(1)CE) in differentiating pseudoprogression from true progression after standard treatment for GBM. METHODS: Seventy-sevenGBM patients, including 51 with true progression and 26 with pseudoprogression,who underwent standard treatment and T(1)CE, were retrospectively enrolled.Clinical information, including sex, age, KPS score, resection extent, neurological deficit and mean radiation dose, were also recorded collected for each patient. The whole tumor enhancementwas manually drawn on the T(1)CE image, and a total of texture 9675 features were extracted and fed to a two-step feature selection scheme. A random forest (RF) classifier was trained to separate the patients by their outcomes.The diagnostic efficacies of the radiomics modeland radiologist assessment were further compared by using theaccuracy (ACC), sensitivity and specificity. RESULTS: No clinical features showed statistically significant differences between true progression and pseudoprogression.The radiomic classifier demonstrated ACC, sensitivity, and specificity of 72.78%(95% confidence interval [CI]: 0.45,0.91), 78.36%(95%CI: 0.56,1.00) and 61.33%(95%CI: 0.20,0.82).The accuracy, sensitivity and specificity of three radiologists’ assessment were66.23%(95% CI: 0.55,0.76), 61.50%(95% CI: 0.43,0.78) and 68.62%(95% CI: 0.55,0.80); 55.84%(95% CI: 0.45,0.66),69.25%(95% CI: 0.50,0.84) and 49.13%(95% CI: 0.36,0.62); 55.84%(95% CI: 0.45,0.66), 69.23%(95% CI: 0.50,0.84) and 47.06%(95% CI: 0.34,0.61), respectively. CONCLUSION: T(1)CE–based radiomics showed better classification performance compared with radiologists’ assessment.The radiomics modelwas promising in differentiating pseudoprogression from true progression. BioMed Central 2021-02-03 /pmc/articles/PMC7860032/ /pubmed/33535988 http://dx.doi.org/10.1186/s12880-020-00545-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Sun, Ying-Zhi
Yan, Lin-Feng
Han, Yu
Nan, Hai-Yan
Xiao, Gang
Tian, Qiang
Pu, Wen-Hui
Li, Ze-Yang
Wei, Xiao-Cheng
Wang, Wen
Cui, Guang-Bin
Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging
title Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging
title_full Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging
title_fullStr Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging
title_full_unstemmed Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging
title_short Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T(1)-weighted Contrast-enhanced Imaging
title_sort differentiation of pseudoprogression from true progressionin glioblastoma patients after standard treatment: a machine learning strategy combinedwith radiomics features from t(1)-weighted contrast-enhanced imaging
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860032/
https://www.ncbi.nlm.nih.gov/pubmed/33535988
http://dx.doi.org/10.1186/s12880-020-00545-5
work_keys_str_mv AT sunyingzhi differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging
AT yanlinfeng differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging
AT hanyu differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging
AT nanhaiyan differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging
AT xiaogang differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging
AT tianqiang differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging
AT puwenhui differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging
AT lizeyang differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging
AT weixiaocheng differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging
AT wangwen differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging
AT cuiguangbin differentiationofpseudoprogressionfromtrueprogressioninglioblastomapatientsafterstandardtreatmentamachinelearningstrategycombinedwithradiomicsfeaturesfromt1weightedcontrastenhancedimaging